Sphingosine 1 phosphate suppresses cyclophosphamide induced follicle apoptosis in human fetal ovarian xenografts in nude mice

Tuesday, May 27, 2014
Antiapoptotic drug sphingosine-1-phosphate suppresses follicular depletion associated with chemotherapeutic agent cyclophosphamide treatment in human fetal ovarian xenografts, potentially providing a new option to prevent infertility associated with cancer treatments.

Read More

Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide treated prepubertal mice

Monday, March 31, 2014
Goserelin administration during prepubertal cyclophosphamide treatment fosters bone elongation but does not protect from ovarian follicular depletion.

Read More

Down regulation of CatSper1 channel in epididymal spermatozoa contributes to the pathogenesis of asthenozoospermia while up regulation of the channel by Sheng Jing San treatment improves…

Monday, February 4, 2013
In rats with cyclophosphamide-induced asthenozoospermia, CatSper1 and sperm motility were significantly reduced, whereas Sheng-Jing-San treatment restored the cyclophosphamide-induced down-regulation of CatSper1 and improved the sperm motility.

Read More

Translate »